{
  "id": 3435,
  "url": "https://nnemf.org/research/3435-histologic-evaluation-of-thermal-capsulorrhaphy-of-human-shoulder",
  "title": "Histologic evaluation of thermal capsulorrhaphy of human shoulder joint capsule with monopolar radiofrequency energy during short- to long-term follow-up.",
  "authors": [
    "Yan Lu",
    "Mark D Markel",
    "Vicki Kalscheur",
    "Jeremy R Ciullo",
    "Jerome V Ciullo"
  ],
  "journal": "Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association",
  "year": "2008",
  "doi": "10.1016/j.arthro.2007.08.004",
  "pmid": "18237705",
  "abstract": "PURPOSE: The purpose of this study was to evaluate the histologic morphology of human shoulder joint capsule after thermal capsulorrhaphy with monopolar radiofrequency energy (mRFE) during short- to long-term follow-up. METHODS: This study comprised 27 patients who received an arthroscopic mRFE thermal capsulorrhaphy and 10 patients without mRFE treatment serving as the control group. Biopsy samples from 3 locations (anterior-superior, anterior-inferior, and posterior-medial) of the shoulder joint capsule were harvested from both the mRFE-treated patients and the control patients. The follow-up time for the mRFE treatment ranged from 3.5 to 62 months, which was divided into 3 groups: short, 3.5 to 12 months; medium, 14 to 25 months; and long, 31 to 62 months. The biopsy samples were analyzed via a histologic scoring system, evaluating an intact synovial layer, subsynovial edema, collagen morphology, cellularity, vascularity, and inflammatory cells. Histologic scores among each follow-up group were compared with each other and with those in the control group. RESULTS: There were no significant differences in the histologic categories of intact synovial layer, subsynovial edema, collagen morphology, and inflammatory cells among the control and mid- and long-term mRFE groups. The short-term mRFE group had greater increased cellularity and vascularity compared with the mid- and long-term groups, which progressively improved toward the appearance in the normal control group with time. CONCLUSIONS: After mRFE capsulorrhaphy, histologic analysis revealed that the mRFE-treated shoulder joint capsule had almost returned to normal, except for persistent cellularity and increased vascularity, which were present at up to 5 years after this procedure. LEVEL OF EVIDENCE: Level III, therapeutic case-control study.",
  "effect": "mixed",
  "evidence": "low",
  "extraction": {
    "studyType": "case_control",
    "studyTypeLabel": "case control",
    "effectDirection": "mixed",
    "evidenceLabel": "Low",
    "population": "Human patients undergoing shoulder joint capsule biopsy after arthroscopic mRFE thermal capsulorrhaphy; controls without mRFE treatment",
    "sampleSize": "37",
    "exposure": "monopolar radiofrequency energy (mRFE) used for arthroscopic thermal capsulorrhaphy · follow-up 3.5 to 62 months (short 3.5–12; medium 14–25; long 31–62 months)",
    "confidencePct": "78",
    "peerReviewed": "yes",
    "mainFindings": "No significant differences were reported for intact synovial layer, subsynovial edema, collagen morphology, and inflammatory cells between controls and mid-/long-term mRFE groups. The short-term mRFE group showed increased cellularity and vascularity versus mid-/long-term groups, with progressive improvement toward control appearance over time; conclusions note persistent cellularity and increased vascularity up to 5 years.",
    "outcomes": [
      "Histologic morphology/scoring of shoulder joint capsule (intact synovial layer",
      "subsynovial edema",
      "collagen morphology",
      "cellularity",
      "vascularity",
      "inflammatory cells)"
    ],
    "limitations": [
      "Radiofrequency exposure parameters (e.g.",
      "frequency",
      "power",
      "SAR) not reported in abstract",
      "Therapeutic case-control design (Level III)",
      "Histologic outcomes only",
      "clinical outcomes not described in abstract"
    ],
    "keywords": [
      "monopolar radiofrequency energy",
      "thermal capsulorrhaphy",
      "shoulder joint capsule",
      "histology",
      "cellularity",
      "vascularity",
      "follow-up"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"case_control\",\n  \"exposure\": {\n    \"band\": null,\n    \"source\": \"monopolar radiofrequency energy (mRFE) used for arthroscopic thermal capsulorrhaphy\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": \"follow-up 3.5 to 62 months (short 3.5–12; medium 14–25; long 31–62 months)\"\n  },\n  \"population\": \"Human patients undergoing shoulder joint capsule biopsy after arthroscopic mRFE thermal capsulorrhaphy; controls without mRFE treatment\",\n  \"sample_size\": 37,\n  \"outcomes\": [\n    \"Histologic morphology/scoring of shoulder joint capsule (intact synovial layer, subsynovial edema, collagen morphology, cellularity, vascularity, inflammatory cells)\"\n  ],\n  \"main_findings\": \"No significant differences were reported for intact synovial layer, subsynovial edema, collagen morphology, and inflammatory cells between controls and mid-/long-term mRFE groups. The short-term mRFE group showed increased cellularity and vascularity versus mid-/long-term groups, with progressive improvement toward control appearance over time; conclusions note persistent cellularity and increased vascularity up to 5 years.\",\n  \"effect_direction\": \"mixed\",\n  \"limitations\": [\n    \"Radiofrequency exposure parameters (e.g., frequency, power, SAR) not reported in abstract\",\n    \"Therapeutic case-control design (Level III)\",\n    \"Histologic outcomes only; clinical outcomes not described in abstract\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.78,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"monopolar radiofrequency energy\",\n    \"thermal capsulorrhaphy\",\n    \"shoulder joint capsule\",\n    \"histology\",\n    \"cellularity\",\n    \"vascularity\",\n    \"follow-up\"\n  ],\n  \"suggested_hubs\": [\n    {\n      \"slug\": \"other\",\n      \"weight\": 0.2,\n      \"reason\": \"Medical/surgical therapeutic use of radiofrequency energy rather than environmental/consumer EMF exposure\"\n    }\n  ]\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/18237705/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=3435",
  "updated": "2026-02-13 07:22:25"
}